Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine zipper and EF-hand containing transmembrane protein 1 pseudogene 2 (LETM1P2) is a classified pseudogene and not a protein-coding gene. Pseudogenes are genomic elements that resemble functional genes but typically contain mutations preventing them from encoding functional proteins[7]. Like other pseudogenes, LETM1P2 may be transcribed into RNA, potentially participating in regulatory networks, such as acting as microRNA decoys or influencing the stability of related mRNAs, though there is no published evidence for a unique biological or pathological role for LETM1P2 specifically[1][3][6][7]. LETM1P2 is not known to be a therapeutic target, biomarker, or directly druggable molecule. Nor is it considered a receptor, enzyme, transporter, or other typical druggable class[1][3][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine zipper and EF-hand containing transmembrane protein 1 pseudogene 2 (LETM1P2).